Effects of sphingosine 1-phosphate, a naturally occurring biologically active lysophospholipid, on the rat cardiovascular system

Japanese Journal of Pharmacology

Volumn 82, Issue 4, 2000, Pages 338-342

  Sugiyama, Atsushi ^a   Aye, Nu Nu ^a   Yatomi, Yutaka ^a   Ozaki, Yukio ^a   Hashimoto, Keitaro ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Adenylate cyclase; Blood pressure; Contraction; Heart rate; Sphingosine 1 phosphate

Indexed keywords

ADENYLATE CYCLASE; POTASSIUM; PROTEIN G; SPHINGOSINE 1 PHOSPHATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; BRADYCARDIA; CARDIOVASCULAR EFFECT; CARDIOVASCULAR PERFORMANCE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG INHIBITION; DRUG SCREENING; ENZYME ACTIVITY; HEART CONTRACTION; HEART RATE; HEART STIMULATION; IN VIVO STUDY; MALE; NONHUMAN; RAT; THROMBOCYTE ACTIVATION;

EID: 0034063355     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.82.338     Document Type: Article

References (16)

1. Meyer zu Heringdorf D, van Koppen CJ and Jakobs KH: Molecular diversity of sphingolipid signalling. FEBS Lett 410, 34-38 (1997)
2. Yatomi Y, Yamamura S, Ruan F and Igarashi Y: Sphingosine 1-phosphate induces platelet activation through an extracellular action and shares a platelet surface receptor with lysophosphatidic acid. J Biol Chem 272, 5291-5297 (1997)
3. Yatomi Y, Igarashi Y, Yang L, Hisano N, Qi R, Asazuma N, Satoh K, Ozaki Y and Kume S: Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. J Biochem 121, 969-973 (1997)
4. Bornfeldt KE, Graves LM, Raines EW, Igarashi Y, Wayman G, Yamamura S, Yatomi Y, Sidhu JS, Krebs EG and Hakomori S: Sphingosine-1-phosphate inhibits PDGF-induced chemotaxis of human arterial smooth muscle cells: spatial and temporal modulation of PDGF chemotactic signal transduction. J Cell Biol 130, 193-206 (1995)
5. Yatomi Y, Ruan F, Hakomori S and Igarashi Y: Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets. Blood 86, 193-202 (1995)
6. + exchange inhibitor, suppresses the reperfusion-induced lethal arrhythmias and "overshoot" phenomenon of creatine phosphate in situ rat heart. J Cardiovasc Pharmacol 33, 116-121 (1999)
7. i protein-coupled plasma membrane receptor by sphingosine-1-phosphate. J Biol Chem 271, 2082-2087 (1996)
8. Goodemote KA, Mattie ME, Berger A and Spiegel S: Involvement of a pertussis toxin-sensitive G protein in the mitogenic signaling pathways of sphingosine 1-phosphate. J Biol Chem 270, 10272-10277 (1995)
9. + current in guinea-pig atrial myocytes by sphingosine-1-phosphate. J Physiol (Lond) 489, 701-707 (1995)
10. Sugiyama A, McKnite S, Adkisson W and Lurie KG: Measurement of adenylylcyclase activity in the AV nodal region of the canine heart: evidence for inhibition by adenosine and acetylcholine. J Cardiovasc Pharmacol 29, 734-739 (1997)
11. Sugiyama A, McKnite S and Lurie KG: Measurement of adenylylcyclase activity with an enzymatic fluorometric assay. Anal Biochem 225, 368-371 (1995)
12. Sugiyama A, Kanazawa S, Gore PF, Field JM, McKnite S, Sutherland DER and Lurie KG: Preoperative assessment of adenylylcyclase activity as a functional marker of islet cell quality after transplantation in rats. J Lab Clin Med 133, 384-390 (1999)
13. Sugiyama A, Takahara A and Hashimoto K: Electrophysiologic, cardiohemodynamic and β-blocking actions of a new ultra-short-acting β-blocker, ONO-1101, assessed by the in vivo canine model in comparison with esmolol. J Cardiovasc Pharmacol 34, 70-77 (1999)
14. Bünemann M, Liliom K, Brandts BK, Pott L, Tseng JL, Desiderio DM, Sun G, Miller D and Tigyi G: A novel membrane receptor with high affinity for lysosphingomyelin and sphingosine 1-phosphate in atrial myocytes. EMBO J 15, 5527-5534 (1996)
15. Zondag GC, Postma FR, Etten IV, Verlaan I and Moolenaar WH: Sphingosine 1-phosphate signaling through the G-protein-coupled receptor Edg-1. Biochem J 330, 605-609 (1998)
16. Igarashi Y, Yatomi Y and Kickler TS: Sphingosine-phosphate content in the plasma of platelet concentrates correlates with poor platelet increments after transfusion and with occurrences of transfusion reactions in patients. Am J Hematol 57, 261-262 (1998)